Ibandronate Sodyòm CAS 138926-19-9

Dayang Chem (Hangzhou) co, Ltd se youn nan dirijan manifaktirè yo ak founisè ibandronate sodyòm cas 138926-19-9 nan Lachin, espesyalize nan bay bon jan kalite pwodwi chimik Customized. Byenveni nan wholesale esansyèl ibandronate sodyòm cas 138926-19-9 te fè nan peyi Lachin isit la epi jwenn lis pri nan faktori nou an. Bon sèvis ak pri rezonab ki disponib.

Entwodiksyon pwodwi:

1.     Spesifikasyon

Dènye espesifikasyon yo ak COA yo pral voye sou demann.

2.     Anbalaj ak anbake

3.     Aplikasyon

Ibandronate se yon nitwojèn ki gen anpil pisan -ki gen bisfosfonat ki itilize pou tretman osteyopowoz la.Sib: Lòt Ibandronate (1.25-2 M) siyifikativman diminye kwasans selil endothelial, pandan y ap ibandronate (2 M) tou siyifikativman diminye fòmasyon tib kapilè-tankou ak ogmante apoplitoz selil endothelial selil yo. Ibandronate (< 100 M) dose-dependently increases VEGF expression in endothelial cells . Ibandronate (< 100 M) inhibits growth of both prostate cancer cell lines (LNCaP and PC-3) in a dose dependent manner .Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly reduces the risk of new morphometric vertebral fractures by 62% and 50% (p = 0.0006), respectively, in osteoporotic women after 3 years' treatment. Ibandronate administered either daily (2.5 mg) or intermittently (20 mg every other day for 12 doses every 3 months) significantly and progressively increases BMD of lumbar spine by 6.5% and 5.7%, respectively, in osteoporotic women after 3 years' treatment . Ibandronate (< 125 mg/kg s.c.) results in a dose dependent increase in bone mineral density (BMD), trabecular bone volume and trabecular number, load to failure (Fmax), and yield load in long bones and vertebrae in ovariectomized rats, and increased trabecular separation in ovariectomized rats is fully prevented by all doses .

4.     Spectre

5.     Atik ki gen rapò

Baj popilè: ibandronate sodyòm cas 138926-19-9, Lachin ibandronate sodyòm cas 138926-19-9 manifaktirè, Swèd, faktori